Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Dominion Energy Inc (D) vs Eli Lilly And Co (LLY) Price & Performance

Dominion Energy IncTrade
Eli Lilly And CoTrade

Price performance (Past 24H)

Key statistics

Dominion Energy Inc vs Eli Lilly And Co — how do they compare? Dominion Energy Inc trades at $61.71 (market cap $54.31B), while Eli Lilly And Co trades at $1,164.15 (market cap $1.04T). The key difference: Eli Lilly And Co is far larger — about 19.1× Dominion Energy Inc's market cap, and Dominion Energy Inc pays the higher dividend (4.32%). Which is the better fit depends on your goals — on Pluang, investors hold Dominion Energy Inc for 76 Days and Eli Lilly And Co for 93 Days on average.

DLLY
Market Cap
$54.31B$1.04T
Volume
6,944,7753,064,878
Sector
UtilitiesHealth
52-Week High
$71.67$1.28K
52-Week Low
$57.08$799.57
Typical Hold Time
76 Days93 Days
Enterprise Value
$108.43B$1.09T
Dividend Yield
4.32%0.59%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Dominion Energy Inc

Dominion Energy (D) trades at $61.53, down 0.76% on the day, with a bearish technical signal driven by moving averages and ADX. The company reported strong earnings beats in recent quarters, with Q3 2026 results pending, and maintains solid profitability with a net income margin of 13.99%. Recent news highlights a proposed merger with NextEra Energy, which could reshape its strategic direction.

The stock offers a consensus price target of $71.56, implying potential upside, supported by a dividend yield. Key risks include execution of the merger, high debt levels, and interest rate sensitivity. Analyst sentiment is mixed with a Hold majority, reflecting cautious optimism amid transformative corporate actions.

Eli Lilly And Co

Eli Lilly (LLY) trades at $1,188.72, up 2.7% on the day, with a bullish technical signal and strong fundamentals. Recent earnings beats, robust revenue growth to $65.18B in 2025, and a net income margin of 33.53% highlight operational strength. Positive news flow centers on next-generation weight-loss drugs, with analyst consensus bullish and a price target of $1,350.

Outlook remains positive given pipeline catalysts in obesity/diabetes markets, though high valuations (P/E 39.9) and rising debt levels pose risks. Competitive intensity and regulatory scrutiny are watchpoints, but institutional support and earnings momentum underpin further upside potential.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

D

No sentiment data available yet.

LLY
69% Buy31% Sell
Avg holding period · 93 Days

Top news

Latest headlines on both assets

About Dominion Energy Inc

Based in Richmond, Virginia, Dominion Energy is an integrated energy company with over 30 gigawatts of electric generation capacity and more than 90,000 miles of electric transmission and distribution lines. Dominion owns a liquefied natural gas export facility in Maryland and is constructing a 5.2 GW wind farm off the Virginia Beach coast.

Read more on D →

About Eli Lilly And Co

Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer

Read more on LLY →